Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bonno van Bellen

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Blood|December 24, 2015
Recurrent venous thromboembolism and abnormal uterine bleeding with anticoagulant and hormone therapy useIda Martinelli, Anthonie W A Lensing, Saskia Middeldorp, et al.
Thrombosis and Haemostasis|May 22, 2015
Two doses of rivaroxaban versus aspirin for prevention of recurrent venous thromboembolism. Rationale for and design of the EINSTEIN CHOICE studyJeffrey I Weitz, Rupert Bauersachs, Jan Beyer-Westendorf, et al.
Thrombosis Research|August 2, 2018
Benefits and risks of extended treatment of venous thromboembolism with rivaroxaban or with aspirinPaolo Prandoni, Anthonie W A Lensing, Martin H Prins, et al.
Blood Advances|April 11, 2018
Risk of recurrent venous thromboembolism according to baseline risk factor profilesMartin H Prins, Anthonie W A Lensing, Paolo Prandoni, et al.
The New England Journal of Medicine|March 21, 2017
Rivaroxaban or Aspirin for Extended Treatment of Venous ThromboembolismJeffrey I Weitz, Anthonie W A Lensing, Martin H Prins, et al.
American Heart Journal|July 31, 2020
Rationale and design for the study Apixaban versus ClopidoGRel on a background of aspirin in patient undergoing InfraPoPliteal angioplasty for critical limb ischemia: AGRIPPA trialRodrigo Bruno Biagioni, Renato Delascio Lopes, Leandro Barile Agati, et al.
Arquivos Brasileiros De Cardiologia|November 29, 2013
[Update and focus on arterial vascular surgeries from the II Guidelines for Perioperative Evaluation of the Brazilian Society of Cardiology]Andre Coelho Marques, Bonno Van Bellen, Bruno Caramelli, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Blood|December 24, 2015
Recurrent venous thromboembolism and abnormal uterine bleeding with anticoagulant and hormone therapy useIda Martinelli, Anthonie W A Lensing, Saskia Middeldorp, et al.
Thrombosis and Haemostasis|May 22, 2015
Two doses of rivaroxaban versus aspirin for prevention of recurrent venous thromboembolism. Rationale for and design of the EINSTEIN CHOICE studyJeffrey I Weitz, Rupert Bauersachs, Jan Beyer-Westendorf, et al.
Thrombosis Research|August 2, 2018
Benefits and risks of extended treatment of venous thromboembolism with rivaroxaban or with aspirinPaolo Prandoni, Anthonie W A Lensing, Martin H Prins, et al.
Blood Advances|April 11, 2018
Risk of recurrent venous thromboembolism according to baseline risk factor profilesMartin H Prins, Anthonie W A Lensing, Paolo Prandoni, et al.
The New England Journal of Medicine|March 21, 2017
Rivaroxaban or Aspirin for Extended Treatment of Venous ThromboembolismJeffrey I Weitz, Anthonie W A Lensing, Martin H Prins, et al.
American Heart Journal|July 31, 2020
Rationale and design for the study Apixaban versus ClopidoGRel on a background of aspirin in patient undergoing InfraPoPliteal angioplasty for critical limb ischemia: AGRIPPA trialRodrigo Bruno Biagioni, Renato Delascio Lopes, Leandro Barile Agati, et al.
Arquivos Brasileiros De Cardiologia|November 29, 2013
[Update and focus on arterial vascular surgeries from the II Guidelines for Perioperative Evaluation of the Brazilian Society of Cardiology]Andre Coelho Marques, Bonno Van Bellen, Bruno Caramelli, et al.
Pageof 2